Patent · US Active

Heterocycle derivatives for treating TRPM3 mediated disorders

US12404266B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

Katholieke Universiteit Leuven · BE

Inventors

Sara Allasia · Mechelen, BE
Philippe Arzel · Wondelgem, BE
Patrick Chaltin · Zétrud-Lumay, BE
Amuri Kilonda · Tienen, BE
Arnaud Marchand · Leuven, BE
Jean-Christophe Vanherck · Leuven, BE
Thomas Voets · Kessel-Lo, BE
Joris Vriens · Wakkerzeel, BE
Melanie Reich · Aachen, DE
André WELBERS · Cologne, DE

Key dates

Filing date	Nov 24, 2021
Grant date	Sep 2, 2025
Priority date	—
Expiry date	Nov 24, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to compounds that are useful for the prevention or treatment of TRPM3 mediated disorders, more in particular disorders selected from pain and inflammatory hypersensitivity. The invention also relates to a method for the prevention or treatment of said TRPM3 mediated disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.